Icotyde Tablet, Film Coated
Product Images NDC 57894-201

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Icotyde (NDC 57894-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Icotyde 01)

Chemical structure of icotrokinra, the active ingredient in ICOTYDE 200 mg film-coated tablets by Janssen Biotech, Inc. The diagram shows the detailed molecular arrangement of atoms and bonds, including heterocyclic rings and peptide bonds, characteristic of the compound.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Carton)

Packaging label for ICOTYDE 200 mg film-coated tablets, oral use, containing icotrokinra. The label displays dosage strength, tablet count of 30 per package, and the labeler Janssen Biotech, Inc., a Johnson & Johnson company. Instructions include storage at controlled room temperature and dispensing a medication guide to patients. The label includes barcode and tamper-evident areas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.